ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 224 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,769 | +210.0% | 276,829 | +179.9% | 0.06% | +266.7% |
| Q1 2023 | $1,861 | -75.0% | 98,890 | -78.8% | 0.02% | -86.1% |
| Q4 2022 | $7,432 | -99.3% | 466,843 | +665.4% | 0.11% | +730.8% |
| Q3 2022 | $998,000 | +58.2% | 60,997 | +36.2% | 0.01% | +62.5% |
| Q2 2022 | $631,000 | -64.7% | 44,773 | -39.3% | 0.01% | -65.2% |
| Q1 2022 | $1,786,000 | +142.7% | 73,761 | +144.3% | 0.02% | +187.5% |
| Q2 2021 | $736,000 | +9.9% | 30,188 | +16.3% | 0.01% | -20.0% |
| Q1 2021 | $670,000 | -77.4% | 25,959 | -53.3% | 0.01% | -65.5% |
| Q4 2020 | $2,970,000 | +389.3% | 55,556 | +277.6% | 0.03% | +141.7% |
| Q3 2020 | $607,000 | -91.1% | 14,712 | -89.6% | 0.01% | -93.2% |
| Q2 2020 | $6,835,000 | +1864.1% | 141,006 | +1613.7% | 0.18% | +831.6% |
| Q1 2020 | $348,000 | -82.6% | 8,228 | -82.4% | 0.02% | -50.0% |
| Q4 2019 | $2,001,000 | – | 46,781 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 27,228,338 | $611,821,000 | 5.19% |
| First Washington CORP | 176,950 | $3,976,000 | 2.06% |
| SECTORAL ASSET MANAGEMENT INC | 783,424 | $17,604,000 | 1.93% |
| HARVEY CAPITAL MANAGEMENT INC | 219,042 | $4,921,000 | 1.84% |
| Ghost Tree Capital, LLC | 400,000 | $8,988,000 | 1.82% |
| Opus Point Partners Management, LLC | 36,733 | $825,000 | 1.62% |
| Palo Alto Investors LP | 1,650,780 | $37,093,000 | 1.59% |
| EMORY UNIVERSITY | 84,714 | $1,904,000 | 1.36% |
| GARRISON BRADFORD & ASSOCIATES INC | 69,000 | $1,550,000 | 1.32% |
| HealthCor Management, L.P. | 1,378,000 | $30,964,000 | 1.05% |